Josh Denny

March 17, 2022

U.S. precision medicine research program releases genomic data

The All of Us Research Program released an initial large batch of genomic data on its cloud-based research platform, the Researcher Workbench, including whole genome sequences of 98,600 research participants and genotype data from 165,200 participants.

By Paul Govern
December 12, 2019

Gregor Mendel would be proud

A computational method that uses hospital billing codes and electronic health records can identify genetic disease cases before clinical teams do.

By Paul Govern
December 11, 2019

VUMC’s Denny selected to lead national ‘All of Us’ program

The National Institutes of Health (NIH) has selected Joshua Denny, MD, MS, vice president of Personalized Medicine at Vanderbilt University Medical Center, to be the chief executive officer of the federal All of Us Research Program.

By Bill Snyder
August 14, 2019

All of Us Research Program Takes Aim at Precision Population Health

Scarcely a year after its national launch, the “All of Us” research program, which aims to accelerate the prevention and treatment of disease, has enrolled more than 230,000 research participants — more than a fifth of its recruitment goal of 1 million people.
All

By Bill Snyder
July 25, 2019

Study ‘ignites’ link between genes and drug response

A national study is seeking to determine whether genetic testing can help physicians choose the best drugs for their patients to relieve pain and depression.

By Bill Snyder
Lisa Bastarache, MS, Josh Denny, MD, MS, and colleagues are helping researchers study associations among de-identified genotype data and electronic health records data. (photo by John Russell)
February 7, 2019

PheWAS Core helps researchers make sense of electronic health record data

Some biomedical researchers may be unsure about routine electronic health record (EHR) data and how useful it ultimately may prove for drawing meaningful, actionable associations that warrant changes to clinical practice and lead to improved clinical outcomes.

By Paul Govern
August 2, 2018

Connecting an asthma gene to leukemia

A receptor previously implicated in asthma may also play roles in other allergic diseases and in leukemia, Vanderbilt researchers have discovered.
By Leigh MacMillan
May 10, 2018

Vanderbilt plays major role in nationwide “All of Us” research program — press release

By Bill Snyder
April 5, 2018

Nashville Biosciences created to leverage wealth of data

Officials with Vanderbilt University Medical Center announced the creation of a wholly owned subsidiary, Nashville Biosciences, to harness the power of its extensive genomic and bioinformatics resources to advance drug and diagnostics discovery and development.
By Bill Snyder
March 15, 2018

Study spots undiagnosed genetic diseases in EHR

Patients diagnosed with heart failure, stroke, infertility and kidney failure could actually be suffering from rare and undiagnosed genetic diseases.
By Craig Boerner
March 1, 2018

Study reveals safety signal from genes that mimic drugs

Prospective mothers taking a new class of cholesterol-lowering drugs might incur higher risk of spina bifida in their future children, according to a study published in the journal Drug Safety by researchers at Vanderbilt University Medical Center.
By Paul Govern
October 26, 2017

Precision medicine discussion

Consuelo Wilkins, M.D., MSCI, and Joshua Denny, M.D., M.S., discussed the potential of precision medicine during their recent Flexner Discovery Lecture.
By Doug Campbell
October 16, 2017

Vanderbilt’s Buntin, Denny elected to National Academy of Medicine

Vanderbilt University’s Melinda Buntin, Ph.D., professor of Health Policy and chair of the department, and Joshua Denny, M.D., M.S., professor of Biomedical Informatics and Medicine and Vice President for Personalized Medicine, are among 70 new members elected to the National Academy of Medicine (NAM), the organization announced this week.
By Paul Govern
1 2 3